Abstract
Weight gain is a known adverse drug reaction associated with the use of antipsychotic medications, potentially leading to obesity and/or other long‐term metabolic complications such as type II diabetes, hypertension, and cardiovascular disease. Reported risk factors associated with antipsychotic‐induced weight gain include young age, female sex, and low baseline body mass index (Correll et al., 2017). Among the approaches used to reverse or reduce weight gain associated with antipsychotics are non‐pharmacological interventions around diet and exercise and pharmacological strategies involving either switching to a different antipsychotic, adding metformin or other weight‐lowering drugs, or reducing the dose of the current antipsychotic.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
